Navigation Links
Vion Pharmaceuticals Announces Presentation of Data from Phase III Trial of Cloretazine(R) (VNP40101M) and Cytarabine in Relapsed Acute Myelogenous Leukemia at the ASCO(R) Annual Meeting
Date:6/2/2008

NEW HAVEN, Conn., June 2 /PRNewswire-FirstCall/ -- VION PHARMACEUTICALS, INC. (Nasdaq: VION) today announced that data from the Phase III trial of its lead anticancer agent Cloretazine(R) (VNP40101M) in combination with cytarabine in patients with first relapse of acute myelogenous leukemia (AML) had been presented at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO(R)) in Chicago, Illinois.

The Phase III trial started in March 2005 and was conducted in 69 sites in North America and Europe. In May 2007, after an interim analysis of 210 patients by the trial's data safety monitoring board (DSMB), the Company suspended treatment and enrollment of patients, and the U.S. Food and Drug Administration (FDA) placed the trial on clinical hold, due to increased mortality in the cytarabine plus Cloretazine(R) (VNP40101M) treatment arm of the study, as compared to the cytarabine plus placebo control arm. In January 2008, the Company announced that the FDA had lifted the clinical hold and that a new trial with a lower dose of Cloretazine(R) (VNP40101M) in combination with cytarabine and increased supportive care measures could be pursued in the future.

The objective response rate of the cytarabine and Cloretazine(R) (VNP40101M) treatment arm of the trial was 37% versus 19% for the control arm. The median response duration was 11.2 months on the treatment arm versus 8.1 months on the control arm. Overall survival was 4.2 months on the treatment arm versus 6 months on the control arm.

The Company reported that on-study mortality (deaths from all causes in less than or equal to 30 days or from adverse events in less than or equal to 60 days from any treatment cycle) was 39% for the cytarabine and Cloretazin
'/>"/>

SOURCE Vion Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/4/2015)... , ... July 05, 2015 , ... Dating a real ... provides the best online millionaire dating service and strives to remove the worries from ... top 1 millionaire dating app of 2015 and readers have responded with ...
(Date:7/3/2015)... ... ... Harvest Hope Food Bank will hopefully be getting a large donation of canned food ... of Greenville SC are making it their mission to collect as many canned items as ... donations from the public as well. As part of the canned food drive, these local ...
(Date:7/3/2015)... ... ... Renowned rhinoplasty surgeon and Symposium Chairman, Dr. Rod J. Rohrich , ... held from March 4th - 6th, the 2016 (a previous announcement had stated the ... to take participants from the basic training and fundamentals of nasal surgery through the ...
(Date:7/3/2015)... ... July 03, 2015 , ... Talcum powder attorneys representing clients in national ... Powder Cancer Lawsuit Center website. Just as the previous version did, the new website ... timely lawsuit updates and ovarian cancer warning information. The site is routinely updated with ...
(Date:7/3/2015)... ... ... Every year, One-to-1 Fitness and the Red Deer Fit Body ... community with free fitness training and indoor fitness boot camp classes for 24 straight ... thousands of charity dollars and ended with a $10,000 donation to the Jumpstart organization. ...
Breaking Medicine News(10 mins):Health News:MillionaireMatchapp.com Publishes the Best Millionaire Dating App and Official Dating Site Reviews 2015 2Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 2Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 3Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 3Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 2Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 3Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 2Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 3
... ... to Corporate eLearning at Drexel University in November , ... Philadelphia, PA (PRWEB) November 11, 2009 -- ... to Corporate eLearning Award" for demonstrating its commitment to training and development through various ...
... ... services, Ms. McKenna and the Beyond the Box team can assist seniors and their loved ... ... Washington, DC based relocation and design firm, Beyond the Box , is pleased to ...
... Positions ... highly automated QT(sm) studies. , ... Rochester, NY (PRWEB) November 11, 2009 -- iCardiac Technologies, Inc., a global ... top five pharmaceutical company has awarded iCardiac a comprehensive "Thorough QT" (TQT) study. ...
... 11 High levels of workplace exposure to Bisphenol-A may ... to a Kaiser Permanente study appearing online in the journal ... , The five-year study examined 634 workers in factories ... control group of workers in factories where no BPA was ...
... University Rollins School of Public Health researchers will present ... American Public Health Association,s annual meeting in Philadelphia, including ... in a large-scale worksite wellness program. Additional ... below. Does faith affect how Southern African-American ...
... Corporation (NYSE: CNC ) announced today that its ... and representatives from the Health Connector, met to reaffirm ... all Massachusetts consumers. , In July of 2009, ... on a voluntary basis. CeltiCare looks forward to ...
Cached Medicine News:Health News:Catholic Health East Named 2009 National Distance Learning Week Award Recipient 2Health News:Catholic Health East Named 2009 National Distance Learning Week Award Recipient 3Health News:Relocation Specialists Beyond the Box Team With Nurse to Help Facilitate Senior Moves 2Health News:Relocation Specialists Beyond the Box Team With Nurse to Help Facilitate Senior Moves 3Health News:Top Five International Pharmaceutical Company Awards Comprehensive Cardiac Safety Study to iCardiac 2Health News:Workplace BPA Exposure Increases Risk of Male Sexual Dysfunction, Kaiser Permanente Study Finds 2Health News:Workplace BPA Exposure Increases Risk of Male Sexual Dysfunction, Kaiser Permanente Study Finds 3Health News:Workplace BPA Exposure Increases Risk of Male Sexual Dysfunction, Kaiser Permanente Study Finds 4Health News:Workplace BPA Exposure Increases Risk of Male Sexual Dysfunction, Kaiser Permanente Study Finds 5Health News:Worksite wellness programs may reduce employee absenteeism 2Health News:CeltiCare Confirms Timetable For Launch of Products With Massachusetts Health Connector 2
(Date:7/2/2015)... According to a new market research report " ... Stimulation, Transcranial Magnetic Stimulation), Application (Depression, Parkinson,s, Tinnitus, Alzheimer,s, Epilepsy, ... MarketsandMarkets, the global Neuromodulation Market is estimated at $3.65 Billion ... 2020, at a CAGR of 11.2% during the forecast period. ... market data T ables and 32 ...
(Date:7/2/2015)... LAKEWAY, Texas , July 2, 2015   ... on being the leading provider for non-invasive aesthetics in ... offer state-of-the-art tattoo removal treatments with the Astanza Duality ... transform their well being through various medical and laser ... patients with unwanted ink a clear solution to their ...
(Date:7/2/2015)... July 2, 2015 Pharma Major Lupin ... ZAO "Biocom" in Russia subject to ... Russian pharmaceutical market which recorded RUB 765 billion in sales, ... in the world in 2014 (IMS Health). For over a ... to continue with this trend, projecting Russia ...
Breaking Medicine Technology:Neuromodulation Market Worth $6.20 Billion by 2020 2Neuromodulation Market Worth $6.20 Billion by 2020 3Neuromodulation Market Worth $6.20 Billion by 2020 4EVO Offers Advanced Laser Tattoo Removal With Astanza Duality In Lakeway, TX 2Lupin Acquires Biocom in Russia 2Lupin Acquires Biocom in Russia 3
... ago, Keli Babcock faced a crisis. A medical condition was ... a ventilator. She couldn,t walk or even maneuver a manual ... But Keli wasn,t about to give in; she aspired to ... with a power wheelchair, one that is powered by batteries ...
... Innovative wireless technology is reshaping the healthcare landscape in ... of Wireless" webcast ( www.ctia.org ) focuses on new ... more value and better health. This is particularly true ... of the U.S. population suffers from at least one ...
Cached Medicine Technology:Mobility Matters: Power Wheelchairs Change the Lives of Medicare Beneficiaries 2Mobility Matters: Power Wheelchairs Change the Lives of Medicare Beneficiaries 3Mobility Matters: Power Wheelchairs Change the Lives of Medicare Beneficiaries 4CTIA-The Wireless Association® November Edition of 'Wonder of Wireless' and Blog to Focus on mHealth 2CTIA-The Wireless Association® November Edition of 'Wonder of Wireless' and Blog to Focus on mHealth 3
... The AB-180 iVAD*, implantable ... a surgically implantable device ... The inflow and outflow ... the VAD and anatomically ...
... HeartMate Left Ventricular Assist System (LVAS): the Vented ... batteries that allow the patient to be mobile, ... by an external Drive Console. Both devices are ... designed to assist the pumping function of the ...
... The Cool Line catheter is inserted into ... in the superior vena cava. The ... which have sterile, temperature-controlled saline flowing within ... with the central circulation. The Cool ...
...
Medicine Products: